Loading
Latest filing published 20 Jun 2018 for Correvio Pharma Corp..
No signal scores available.
Only one filing by Richard Glickman is known so far (20 June 2018): a transaction, in Correvio Pharma Corp. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.